Anvisa approves new drug for advanced lung cancer
Safety Classified by Officially
The medication is indicated for patients with locally advanced or metastatic disease
This is an extract. The publication continues at the source.
Read the original at the source: https://www.gov.br/anvisa/en/updates/anvisa-approves-new-drug-for-advanced-lung-cancer
Officially imported this from Agência Nacional de Vigilância Sanitária (Anvisa)’s own source and shows an extract. If you work there, claiming the profile and verifying the domain lets you choose to show the full text here.
Provenance
- Organization
- Agência Nacional de Vigilância Sanitária (Anvisa) — imported from official source
- Official source
- https://www.gov.br/anvisa/++api++/@search?portal_type=News%20Item&sort_on=effective&sort_order=reverse&b_size=25&metadata_fields=effective&metadata_fields=UID API
- Imported
- October 23, 2026 15:00
- Versions
- 1 recorded
- Identity
-
7f9278613544482bb924351870ea143d